Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Template:SUIT-003 O2 ce D061"

From Bioblast
Line 15: Line 15:


|-
|-
| ce2Omy
| (ce2Omy)
| ''[[L]]''
| ''[[L]]''
| ย 
| ย 
| ย 
| ย 
| ce1;ce2Omy
| ce1;(ce2Omy)


{{Template:SUIT L(n)}} ย 
{{Template:SUIT L(n)}} ย 
Line 28: Line 28:
| ย 
| ย 
|
|
| ce1;ce2Omy;ce3U
| cce1;(ce2Omy);ce3U


{{Template:SUIT U*}} {{Template:SUIT ET}}
{{Template:SUIT U*}} {{Template:SUIT ET}}
Line 37: Line 37:
| ย 
| ย 
|
|
| ce1;ce2Omy;ce3U;ce4Rot
| ce1;(ce2Omy);ce3U;ce4Rot
ย 
{{Template:SUIT ROX}}
{{Template:SUIT ROX}}


|-
|-
| ce5S
| ce5DMSO
|
| ''[[ROX]]''
| ย 
| ย 
|
|
| ce1;ce2Omy;ce3U;ce4Rot;ce5Snv
| ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO


{{Template:SUIT Rot}} {{Template:SUIT S}}
{{Template:SUIT ROX}}


|-
|-
| ce6Mnanv
| ce6DMSO
| ''[[ROX]]''
| ''[[ROX]]''
| ย 
| ย 
|
|
| ce1;ce2Omy;ce3U;ce4Rot;ce5Snv;ce6Mnanv
| ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO


{{Template:SUIT ROX}}
{{Template:SUIT ROX}}
Line 64: Line 63:
| ย 
| ย 
|
|
| ce1;ce2Omy;ce3U;ce4Rot;ce5Snv;ce6Mnanv;ce7Ama
| ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama


{{Template:SUIT ROX}}
{{Template:SUIT ROX}}
|}
|}

Revision as of 12:09, 26 June 2019

MitoPedia: SUIT

Steps and respiratory states

Ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama.png

Step State Pathway Q-junction Comment - Events (E) and Marks (M)
ce1 ROUTINE ce1

ROUTINE respiration in the physiological coupling state R. Externally added permeable substrates could contribute to this respiratory state.


(ce2Omy) L ce1;(ce2Omy)

Non-phosphorylating resting state (LEAK state); LEAK respiration L(n) in the absence of ADP, ATP, AMP (no adenylates).

ce3U E cce1;(ce2Omy);ce3U

Uncoupler titration (avoiding inhibition by high uncoupler concentrations) to obtain electron transfer (ET) capacity E (noncoupled ET-state). Test for limitation of OXPHOS capacity P by the phosphorylation system (ANT, ATP synthase, phosphate transporter) relative to ET capacity E in mt-preparations: E-P control efficiency and E-L coupling efficiency. In living cells: E-R control efficiency and E-L coupling efficiency. Noncoupled electron transfer state, ET state, with ET capacity E.

ce4Rot ROX ce1;(ce2Omy);ce3U;ce4Rot

Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.

ce5DMSO ROX ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO

Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.

ce6DMSO ROX ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO

Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.

ce7Ama ROX ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama

Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.